SEC Filings

Filing date	Form	Description	View
02/07/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-001567.pdf 0001179110-19-001567.rtf 0001179110-19-001567.xls
02/07/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-001570.pdf 0001179110-19-001570.rtf 0001179110-19-001570.xls
02/07/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-001572.pdf 0001179110-19-001572.rtf 0001179110-19-001572.xls
02/07/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-001574.pdf 0001179110-19-001574.rtf 0001179110-19-001574.xls
02/06/19	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000215457-19-005828.pdf 0000215457-19-005828.rtf
01/07/19	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-19-001153.pdf 0001104659-19-001153.rtf 0001104659-19-001153.xls
01/03/19	8-K/A	Amendment to a previously filed 8-K	View HTML 0001104659-19-000559.pdf 0001104659-19-000559.rtf 0001104659-19-000559.xls
12/20/18	CT ORDER	CT ORDER	View HTML 9999999997-18-009627.pdf
12/03/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-070942.pdf 0001104659-18-070942.rtf 0001104659-18-070942.xls
11/21/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-013106.pdf 0001179110-18-013106.rtf 0001179110-18-013106.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools